Minglu Liang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Natural product bioactivities and synthesis 5
-
- NF-κB Signaling Pathways 4
- Co-authors
- Kai Huang (36 shared papers)Wenjing Xu (9 shared papers)Cheng Wang (6 shared papers)Fengxiao Zhang (10 shared papers)Yiqing Li (3 shared papers)Shan Deng (3 shared papers)Yang Liu (2 shared papers)Zhangyin Ming (6 shared papers)
- Journals
- European Journal of Pharmacology (3 papers)Frontiers in Pharmacology (3 papers)International Journal of Biological Sciences (3 papers)Archives of Biochemistry and Biophysics (2 papers)Phytotherapy Research (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Minglu Liang
49 papers receiving 931 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 144
- Biochemistry 41
- Molecular Biology 394
- Nephrology 34
- Immunology 102
Countries citing papers authored by Minglu Liang
This map shows the geographic impact of Minglu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minglu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minglu Liang more than expected).
Fields of papers citing papers by Minglu Liang
This network shows the impact of papers produced by Minglu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minglu Liang. The network helps show where Minglu Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Minglu Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 107 | |
| 2 | 2020 | 59 | |
| 3 | 2017 | 50 | |
| 4 | 2016 | 42 | |
| 5 | 2018 | 38 | |
| 6 | 2022 | 35 | |
| 7 | 2019 | 35 | |
| 8 | 2015 | 33 | |
| 9 | 2022 | 31 | |
| 10 | 2020 | 29 | |
| 11 | 2014 | 28 | |
| 12 | A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma. | 2018 | 28 |
| 13 | 2020 | 25 | |
| 14 | 2019 | 25 | |
| 15 | 2020 | 25 | |
| 16 | 2018 | 24 | |
| 17 | 2022 | 24 | |
| 18 | 2019 | 23 | |
| 19 | 2019 | 22 | |
| 20 | 2017 | 21 |
About Minglu Liang
Minglu Liang is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Physiology and Surgery, having authored 55 papers that have together received 935 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (7 papers), Natural product bioactivities and synthesis (5 papers), PARP inhibition in cancer therapy (5 papers), NF-κB Signaling Pathways (4 papers), Flavonoids in Medical Research (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Cardiac Fibrosis and Remodeling (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). The work is most often cited by research in Cancer Research (144 citations), Biochemistry (41 citations), Molecular Biology (394 citations), Nephrology (34 citations) and Immunology (102 citations). Minglu Liang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kai Huang, Wenjing Xu, Cheng Wang, Fengxiao Zhang, Yiqing Li, Shan Deng, Yang Liu, Zhangyin Ming, Xingwen Da and Dan Huang. Their work appears in journals such as European Journal of Pharmacology, Frontiers in Pharmacology, International Journal of Biological Sciences, Archives of Biochemistry and Biophysics and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.